SAMANTHA GERISH: Open Payments
NPI 1790347151 · BERKELEY HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,256 in 223 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $504 · 2025 $3,256
Food & beverage: $3,057Education: $199
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 66 | $712 |
| ABBVIE INC. | 27 | $351 |
| Botanix SB Inc | 22 | $324 |
| UCB, Inc. | 21 | $307 |
| Incyte Corporation | 16 | $265 |
| Lilly USA, LLC | 12 | $205 |
| Regeneron Healthcare Solutions, Inc. | 11 | $173 |
| Janssen Biotech, Inc. | 5 | $162 |
| Arcutis Biotherapeutics, Inc. | 7 | $108 |
| Amgen Inc. | 5 | $89 |
Products named: ILUMYA, SOFDRA, Bimzelx, OPZELURA, SKYRIZI, DUPIXENT, TREMFYA, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
